Short answer · Medically reviewed summary · Last updated: 2023-07-13
Can people with PMM2-CDG work? Yes, individuals with PMM2-CDG (Phosphomannomutase 2-congenital disorder of glycosylation) can indeed work and contribute to various fields depending on the severity of their condition and the specific symptoms they experience. PMM2-CDG is a rare genetic disorder that affects the body's ability to produce certain proteins and sugars, leading to a wide range of physical and cognitive impairments. Employment Opportunities: While the impact of PMM2-CDG can vary significantly from person to person, many individuals with this condition can find suitable employment opportunities.
Can people with PMM2-CDG work?
Yes, individuals with PMM2-CDG (Phosphomannomutase 2-congenital disorder of glycosylation) can indeed work and contribute to various fields depending on the severity of their condition and the specific symptoms they experience. PMM2-CDG is a rare genetic disorder that affects the body's ability to produce certain proteins and sugars, leading to a wide range of physical and cognitive impairments.
Employment Opportunities:
While the impact of PMM2-CDG can vary significantly from person to person, many individuals with this condition can find suitable employment opportunities. It is important to consider the individual's abilities, limitations, and preferences when determining the type of work they can perform. Some potential employment options for people with PMM2-CDG include:
Workplace Accommodations:
It is crucial for employers to provide appropriate accommodations to individuals with PMM2-CDG to ensure their success in the workplace. Accommodations can include:
Conclusion:
People with PMM2-CDG can certainly work and contribute to society in various ways. It is important to recognize their unique abilities and provide appropriate accommodations to ensure their success in the workplace. By fostering an inclusive and supportive environment, individuals with PMM2-CDG can lead fulfilling and productive professional lives.